Inflammatory bowel disease

Letter
Year 2025 / Volume 117 / Number 10
620-621
DOI: 10.17235/reed.2024.10861/2024
Julio César Moreno-Alfonso, Sara Pérez Ollo, Sharom Barbosa-Velásquez, Ada Molina Caballero, Alberto Pérez Martínez, María Concepción Yárnoz Irazábal,
Crohn's disease (CD) is a relapsing-remitting inflammatory bowel disease (IBD) affecting the gastrointestinal tract. Its symptoms are nonspecific, with weight loss, diarrhea, and abdominal pain being classic,...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 10
617-618
DOI: 10.17235/reed.2024.10834/2024
Julio César Moreno-Alfonso, Miguel Ángel Sánchez Durán, Sharom Barbosa-Velásquez, Ada Molina Caballero, Alberto Pérez Martínez, María Concepción Yárnoz Irazábal,
Ulcerative colitis (UC) is a chronic, relapsing inflammatory bowel disease (IBD) of the colon. Its presentation is varied, with the main symptoms being mucosanguineous diarrhea, abdominal pain, and weight...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 10
613-614
DOI: 10.17235/reed.2024.10778/2024
Julio César Moreno-Alfonso, Sharom Barbosa-Velásquez, Ada Molina Caballero, Alberto Pérez Martínez, María Concepción Yárnoz Irazábal,
Crohn's disease (CD) is a type of inflammatory bowel disease (IBD) characterized by chronic, transmural, and relapsing inflammation that can affect any segment of the gastrointestinal tract, from the oral...
Reader rating:
Original
Year 2025 / Volume 117 / Number 9
506-512
DOI: 10.17235/reed.2025.10923/2024
Laura Lorenzo González, Daniel Barranco Castro, Victoria Alejandra Jiménez García, Teresa Romero García, Rocío Ferreiro Iglesias, Isabel Vera Mendoza, Blas José Rodríguez Gómez, Manuel Rodríguez-Téllez, Cloé Charpentier, Federico Argüelles-Arias,
Background and aims: accurate endoscopic assessment is crucial for treatment decisions in Crohn’s disease (CD), but endoscopic scores are complex and not easily applicable in routine practice. This study...
Reader rating:
Digestive Diseases Image
Year 2025 / Volume 117 / Number 8
457-458
DOI: 10.17235/reed.2023.10097/2023
Andreia Rei, Irina Mocanu, Carlos Pontinha, Isabel Medeiros,
This case reports illustrates a 44-year-old Caucasian male with ileal Crohn´s disease under combined immunosuppression that first presented with unspecific constitutional symptoms, newly pancytopenia and...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 7
406-407
DOI: 10.17235/reed.2024.10445/2024
María Martínez Burgos, Raúl Vicente Olmedo Martín, Víctor Amo Trillo, Patricia Romero Cara, José Mostazo Torres, Miguel Jiménez Pérez,
Following the growing trend of trying to individualise treatment in inflammatory bowel disease and in view of the challenge posed by elderly patients requiring biologic treatments, we have conducted a...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 6
359-360
DOI: 10.17235/reed.2024.10822/2024
Marta Fernández Carrasco, Alejandro Rodríguez Mateu, Olga Sánchez García,
The differential diagnosis between Crohn’s disease (CD) and intestinal tuberculosis (ITB) continues to pose a diagnostic challenge, as clinical presentation can be indistinguishable, as well as findings...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 6
342-343
DOI: 10.17235/reed.2024.10405/2024
Kazuhiro Furukawa, Masahiro Oda, Osamu Watanabe, Masanao Nakamura, Takeshi Yamamura, Keiko Maeda, Kensaku Mori, Hiroki Kawashima,
Since even subtle mucosal changes may be depicted using virtual endoscopy created by the three-dimensional reconstruction of MDCT images, we developed a novel diagnostic imaging system that integrates...
Reader rating:
Original
Year 2025 / Volume 117 / Number 5
241-248
DOI: 10.17235/reed.2024.10731/2024
Rubén Pampín Sánchez, Alba Gonzalo González, Santiago Fuertes Camporro, Ane Goenaga Ansola, Andrea Fórneas Sangil, Sonia Tembrás Martínez, Pilar Varela Trastoy, Cristina Martínez-Múgica Barbosa,
Background and purpose: ustekinumab is a monoclonal antibody approved for the treatment of moderate to severe Crohn’s disease (CD) and ulcerative colitis (UC). In spite of being an effective treatment,...
Reader rating:
Letter
Year 2025 / Volume 117 / Number 5
289-290
DOI: 10.17235/reed.2024.10378/2024
Akira Hokama,
I read with great interest the letter by Calderón et al., who clearly described effectiveness of hyperbaric oxygen therapy (HBOT) for refractory ischemic ulcer at the ileorectal anastomosis in Crohn’s...
Reader rating:

Page 1 of 18
1
2
3
4
5
6
7
>>
Submission and tracking of manuscripts
Instructions to authors

Submission and tracking

Asociación Española de Ecografía Digestiva Sociedad Española de Endoscopia Digestiva Sociedad Española de Patología Digestiva
The Spanish Journal of Gastroenterology is the official organ of the Sociedad Española de Patología Digestiva, the Sociedad Española de Endoscopia Digestiva and the Asociación Española de Ecografía Digestiva
Cookie policy Privacy Policy Legal Notice © Copyright 2025 y Creative Commons. The Spanish Journal of Gastroenterology